These assets aim to move beyond the current weekly injection paradigm, signalling a future where extended dosing intervals could become central to maintenance strategies [16]
However, this same mechanism also underlies many of the gastrointestinal side effects reported by patients
37% of people taking 120mg of orlistat 3 times per day lose 5% or more of their starting weight after 12 weeks
We currently offer a range of ready-to-use products targeting GCGR, including recombinant ECD proteins, synthetic nanodisc full-length multi-transmembrane proteins, biosimilar reference antibodies, and biotin-labeled antibodies
It involves: Clinical Assessment: A thorough review of your BMI, medical history, and weight loss goals
If you develop any of these serious side effects, go immediately to your nearest hospitals emergency department